Predicting the Drug Clearance Pathway with Structural Descriptors

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Chemistry and Cheminformatics
• Drug Discovery and Development

Background:

• Drug clearance, via renal elimination or hepatic metabolism, is a critical pharmacokinetic parameter influencing drug efficacy and safety.
• Accurate prediction of clearance pathways for new drug candidates is vital to mitigate risks of adverse effects and drug-drug interactions.
• Current in vivo methods for predicting human drug clearance are often time-consuming, expensive, and rely on preclinical animal data.

Purpose of the Study:

• To establish a relationship between the structural parameters of drug molecules and their primary clearance pathways.
• To develop a predictive model for drug clearance mechanisms based on molecular descriptors.

Main Methods:

• Literature data was used to determine the clearance pathway for each drug.
• A mechanistic model was developed using various structural descriptors, including Abraham solvation parameters, topological polar surface area, hydrogen-bond donors/acceptors, rotatable bonds, molecular weight, logP, and logD7.4.
• Logistic regression was employed to build predictive models based on identified structural parameters.

Main Results:

• Compounds with logD7.4 > 1 or with 0-1 hydrogen-bond donors are predicted to undergo hepatic metabolism.
• Chemicals with logD7.4 < -2 are predicted to be cleared via renal elimination.
• Logistic regression models utilizing five structural parameters achieved prediction accuracies of 84.8% and 84.4% for compounds with -2 < logD7.4 < 1.

Conclusions:

• The developed model accurately predicts clearance pathways for new drug candidates.
• Hydrophobicity (logD7.4) and the number of hydrogen-bonding functional groups are key descriptors for evaluating drug clearance pathways.
• This computational approach offers a valuable tool for early-stage drug development, improving efficiency and safety assessments.